New Product Newswire for March 22, 2004
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
FDA Approves Denosumab-Kyqq as Biosimilar for Prolia, Xgeva
Episode 8: Stay in Sync with Innovations in Medication Decision Support
FDA Approves Biosimilars for Prolia, Xgeva
FDA Approves Lecanemab Subcutaneous Formulation as Maintenance Dose for Alzheimer Disease
FDA Approves First Generic GLP-1 Liraglutide for Weight Loss
FDA Approves COVID-19 Vaccines for Patients 65 Years and Older